Literature DB >> 25467386

First ever observation of the intermediate of phosphonium salt and ylide hydrolysis: P-hydroxytetraorganophosphorane.

Peter A Byrne1, Yannick Ortin, Declan G Gilheany.   

Abstract

P-Hydroxytetraorganophosphorane, the long-postulated intermediate in phosphonium salt and ylide hydrolysis, has been observed and characterised by low temperature NMR, finally definitively establishing its involvement in these reactions. The results require modification of the previously accepted mechanism for ylide hydrolysis: P-hydroxytetraorganophosphorane is generated directly by 4-centre reaction of ylide with water.

Entities:  

Year:  2015        PMID: 25467386     DOI: 10.1039/c4cc08644a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

1.  Selective formation of heteroaryl thioethers via a phosphonium ion coupling reaction.

Authors:  Ryan G Anderson; Brianna M Jett; Andrew McNally
Journal:  Tetrahedron       Date:  2017-12-21       Impact factor: 2.457

2.  P(v) intermediate-mediated E1cB elimination for the synthesis of glycals.

Authors:  Fen Liu; Haiyang Huang; Longgen Sun; Zeen Yan; Xiao Tan; Jing Li; Xinyue Luo; Haixin Ding; Qiang Xiao
Journal:  Chem Sci       Date:  2022-04-22       Impact factor: 9.969

3.  A Unified Approach to Couple Aromatic Heteronucleophiles to Azines and Pharmaceuticals.

Authors:  Ryan G Anderson; Brianna M Jett; Andrew McNally
Journal:  Angew Chem Int Ed Engl       Date:  2018-08-27       Impact factor: 15.336

4.  Synthesis of phosphine oxide based amphiphilic molecules via ring-opening Wittig olefination of a macrocyclic phosphoranylidene and their property study as non-ionic surfactants.

Authors:  Jin Xu; Anqi Chen; Brendan Burkett; Qi Hua Ng; Kok Ping Chan
Journal:  RSC Adv       Date:  2018-06-05       Impact factor: 3.361

5.  Nucleophilic arylation with tetraarylphosphonium salts.

Authors:  Zuyong Deng; Jin-Hong Lin; Ji-Chang Xiao
Journal:  Nat Commun       Date:  2016-01-29       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.